Cost Comparison of Deep Drain Stimulation (DBS) and Continued Subcutaneous Apomorphine Infusion (CSAI) in Patients with Advanced Parkinson's Disease
Value Health
.
2014 Nov;17(7):A395.
doi: 10.1016/j.jval.2014.08.881.
Epub 2014 Oct 26.
Authors
Autiero S Walleser
1
,
S Eggington
1
,
A Valyi
2
Affiliations
1
Medtronic International Trading Sarl, Tolochenaz, Switzerland.
2
Medtronic Ltd UK & Ireland, Watford, UK.
PMID:
27200927
DOI:
10.1016/j.jval.2014.08.881
No abstract available